© Drug Hunter Inc. 2018-2023
Home > Merck IDO1 inhibitor
heme-displacing IDO1 inhibitor
human predicted QD dose of 26 mg
from 260k MS-based screen and SBDD
ACS Med. Chem. Lett. Mar. 10, 2020
Merck, Boston, MA
Merck IDO1 inhibitor (Merck heme-displacing oral IDO1 inhibitor)
Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.
Request a trial to access insights powering the pros in our industry.
Molecules of the Month
Molecule of the Year